Maplirpacept (TTI-622, PF-07901801) is a fusion protein consisting of the CD47-binding domain of human SIRPalpha linked to the Fc region of human IgG4. Maplirpacept enhances phagocytosis by blocking CD47[1][2].
Purity:
97.73
CAS Number:
[2631667-06-4]
Target:
CD47
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted